SCHEMBL19386175

SCHEMBL19386175

CNC(=O)c1cccc(-c2ccc(O[C@H]3OC(CO)C(O)C(O)C3O)cc2)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20056402 1.00 — —
SCHEMBL22829682 1.00 — —
SCHEMBL14120343 1.00 — —
SCHEMBL16027276 0.92 HK1 (0.51) —
SCHEMBL16027274 0.92 HK1 (0.51) —
SCHEMBL15639049 0.92 HK1 (0.47) —
SCHEMBL15639048 0.92 HK1 (0.47) —
SCHEMBL16027267 0.91 HK1 (0.48) —
SCHEMBL16027248 0.91 — —
SCHEMBL20056314 0.91 — —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3432892-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE Fimbrion Therapeutics, Inc. (US) 2019-01-30 — — EP disclosed
WO-2017165619-A1 MANNOSE-DERIVED ANTAGONISTS OF FIMH USEFUL FOR TREATING DISEASE FIMBRION THERAPEUTICS, INC. (US) 2017-09-28 — — WO disclosed
Send feedback